AI FOR SCIENCE · ON THE RECORD
adsilico
A University of Leeds spinout whose Virtual Chimera platform builds virtual hearts and blood vessels from anonymised clinical scans with generative AI, then runs physics simulations of how a heart valve, stent or other implant behaves in each, across a population varied by age, sex, ethnicity, body size and disease.
Full funding record →On the timeline →People filter →
Recent timeline
People
Only people the AI4S.fyi record has named: in a round, a timeline entry, commentary, an interview or a sourced role. Not the full team.
Named on AI4S.fyi
Funding rounds tracked
- 2026-10-26Series A · £10MconfirmedLed by PXN Ventures · Existing investors Northern Gritstone, ParkwalkStated use: further develop the virtual heart models, expand into neurovascular devices such as flow diverters for brain aneurysms, and grow the team from 14 to 34
Each round links to its line on the funding record, with its source.
Also in Biology data and tools on the funding board
The other companies the funding board files under the same field, latest round first. A list of what the record tracks, not a ranking or a market map.
- 2026-10-27OmabitSeed · $2MSoftware that analyses a drug developer's own preclinical, clinical and genomic data alongside published research: a scientist chooses the question in plain language and it runs the analysis and writes it up, starting with clinical development, biomarker and translational teams.
- 2026-10-20Electric PlantSeed · $11.2MMakes electrodes and low-cost sensors that record a living plant's electrical signals from its stem or trunk, and Bombadil, a model trained on those signals across about a hundred species that estimates leaf stress measures such as photosynthetic efficiency and water stress, for farming, forestry and plant care.
- 2026-10-10BIOTREESeries B · nearly CNY 100MA mass-spectrometry service company for metabolomics and proteomics, with its own metabolite standards library. It is moving into single-cell and spatial omics and pitches that data (its MetCell single-cell metabolomics in particular) as training material for virtual-cell models.
- 2026-10-08Onyx BioSeed · $8MRuns paid, at-home research studies that measure the same people's immune systems over months and years (proteins, single-cell gene expression, metabolites, genetics) beside their clinical histories, processes every sample in its own Berkeley lab, and offers the data to biopharma and AI model developers as a 'virtual immune system'. Its first studies cover autoimmune disease and immune ageing.
- 2026-10-08OptoSeekerPre-A · over CNY 50MBuilds lab instruments that move and screen single cells with light (optoelectronic tweezers), for antibody discovery, cell-line development and cell and gene therapy. It pitches the time-stamped single-cell function data they produce as training data for AI biology models.
- 2026-10-07RivercellSeed · $25MGenerates time-resolved, multimodal single-cell data on how human cells respond to drugs and genetic changes, on its own platform and automated wet lab, to train an 'AI virtual cell' model that predicts those responses.
This page compiles what AI4S.fyi has recorded and links each item to its source. It is not a grade of the organization and not its complete history: a blank means the record has not caught up as often as it means nothing happened.